Home | About | RSS Feed | Contact and Publicity Guidelines | Comment Policy the Law, the Universe, and Everything 

Search


Concurring Opinions is a
general-interest legal blog
operated by Concurring
Opinions LLC, a Pennsylvania
Limited Liability Corporation.

jr_114_9780195367195_bnr

jr_114_9780195383768_bnr

advertise-here4


FC-CO(SS)

Our Podcast

Subscribe to Law Talk

law-rev-contents2.jpg


  • Posts by Author

  • Categories

  • Archives


  • Recent Comments

    • Observer on Ricci: Color-Blind Standards in a Race Conscious Society?

    • RJ on Ricci: Color-Blind Standards in a Race Conscious Society?

    • RJ on Ricci and Briscoe as Disparate Impact Cases

    • Mike Rich on Negligent Corpse Mishandling

    • anon on Privacy and Tattletales

    • orly lobel on At CELS, Hoping to Blog

    • harry brooks on Ricci: Color-Blind Standards in a Race Conscious Society?

    • RJ on Ricci: Color-Blind Standards in a Race Conscious Society?

    • Michael H Schneider on Negligent Corpse Mishandling

    • flood pictures on Public opinion on same-sex marriage

    • gtownstudent on And Justache For All at GW Law

    • AF on Ricci and Briscoe as Disparate Impact Cases

    • RJ on Ricci and Briscoe as Disparate Impact Cases

    • Maryland Conservatarian on Ricci: Color-Blind Standards in a Race Conscious Society?

    • Daniel S. Goldberg on Negligent Corpse Mishandling

  •  

    Site Meter

Minding the Obesity Epidemic

posted by Frank Pasquale

supersize.jpgJeanne Whalen at the WSJ has a fascinating piece on a slew of new obesity drugs now in clinical trials. There’s a lot to comment on, but I was struck by a chart on the front page, giving the following rates of obesity (BMI > 30) in different countries in 2005:

US: 39%

UK: 23%

France: 7%

China: 2%

Japan: 2%

These are pretty shocking figures. The chart mentions that the obesity rate in the US was 35% in 2002….so the percentage by which obesity increased in the US in three years is double the overall percentage in the Asian countries mentioned. How is it that twenty times as many Americans are obese than Chinese or Japanese nationals?

I plan to look for answers in Avner Offer’s The Challenge of Affluence: Self-Control and Well-Being in the United States and Britain Since 1950. The book is a masterpiece of meta-analysis, reportage, and Jon Elster-style explication of the microfoundations of social action. Offer’s thesis is (inadequately) summarized below:

Resources and cravings do not map precisely on to well-being. . . .Over the last two decades, a new understanding began to emerge, especially from psychology and economics, that what we want and choose can often fail to deliver, and can even be counter-productive. . . . This understanding is the work of many inquiries and disciplines. My effort here is to extrapolate it to the personal dynamics of affluence during the last six decades. . . .

Offer has a whole chapter explaining the ways in which high levels of competition, stress, and inequality in American and British society contribute to compulsive, mindless, or otherwise unhealthy eating.

Kudos also to Cass Sunstein for exploring the issue in his review of Brian Wansink’s diet book Mindless Eating . Bottom line:

Wansink has concluded that much eating is mindless. Americans are fat not because they have made a rational calculation that French fries are so yummy that they are worth the costs in health and svelte. Nor are French fries essentially irresistible. Often Americans eat because of contextual cues, or “hidden persuaders,” to which they are blind, but which greatly affect their behavior. . . . Wansink’s real subject is choosing, not eating, so even thin people should read it.

Philosophers ranging from Aristotle to Dewey recognized the ultimate importance of habit, and Wansink brings their insights into a world of diet fads sorely in need of philosophical perspectives.

So what’s the bottom line for law? Well, given the insights of Offer and Wansink, the agenda for regulation currently pushed at The Situationist makes a lot more sense.


The new obesity control drugs may also have some interesting implications for medical marijuana laws. Consider the mechanism of action of Acomplia:

Acomplia, known by the generic name rimonabant, attacks obesity in a new way, by blocking receptors in the brain and in fat cells that help regulate appetite and metabolism. Cannabis, the active ingredient in marijuana, acts on the same receptors, which is believed to explain why marijuana users often get hungry.

I suppose this makes Acomplia something of an anti-marijuana, but the larger parallel may help support the thesis of Richard Grandpre’s provocative Cult of Pharmacology: that legal and illegal drugs have mechanisms of action that sometimes are strikingly similar. (For the opposite view, see the Peter Kramer review on the Amazon page.)


 March 29, 2007 at 8:02 pm   Posted in: Health Law   Print This Post Print This Post

Responses (8)

  1. SalvoSensu - March 29, 2007 at 11:45 pm

    When are we all going to take a long rational look at the statistics? This obesity epidemic, which began in the late eighties/early ninties directly correlates with the introduction and use of high fructose corn syrup in soft drinks and processed foods. So does the current epidemic of childhood obesity and diabetes. There is evidence for this, solid evidence, published all over the web! And as the use of that poison grows, so do these epidemics of illness. Its being used quite deliberately by the junk food industry because its been proven to cause binge eating as a side effect! Its worse than trans-fatty acids and more insidious than cigarettes! Wake up and smell the poison, people!

  2. Camilo - September 20, 2007 at 5:52 pm

    If you have tried all kind of diets and exercises to loss weight and you haven’t bring it, you need more help with

    that problem.

    Every body is different in composition and metabolism. Perhaps you need any medicine to obtain the hoped results.

    If you visit this website, you can find those medicines and you can get them in a simple way:

    http://www.trustedprescriptionsonline.com

    Moreover, you can make here your questions online.

  3. Camilo - September 20, 2007 at 5:52 pm

    If you have tried all kind of diets and exercises to loss weight and you haven’t bring it, you need more help with

    that problem.

    Every body is different in composition and metabolism. Perhaps you need any medicine to obtain the hoped results.

    If you visit this website, you can find those medicines and you can get them in a simple way:

    http://www.trustedprescriptionsonline.com

    Moreover, you can make here your questions online.

  4. Cucufate - October 30, 2007 at 11:44 am

    If you want to reduce your weight, you need to do a lot of exercise to accelerate your metabolism. It’s better if you do cardiovascular exercise, because this kind of exercise helps you burn fat…

    You should begin with a good eating plan, combining fats and sweets with fruits and vegetables. It will be better if you drink at least eight glasses of water daily to control your calories and your cholesterol.

    If you want you can use some pills to control your weight and to accelerate the process of burning fat.

    I know some pills which you can use to reduce your weight. Those pills are Xenical and Hoodia. Their results are excellent and fast.

    Visit this website to find more information:

    http://www.todoenmedicamentos.com

  5. bodydetoxdiet - August 3, 2009 at 7:56 pm

    lots of americans and europeans are getting obese these days because of over-eating. people should be controlling what they eat or they should workout their body to burn fat.

  6. acnesolutions health site - September 13, 2009 at 12:45 am

    the best solution for obesity is none other than Exercise and Proper diet. i would try to avoid slimming pills or fat burning food supplements

  7. The Modern Man Boob | Man Boob Help - October 5, 2009 at 12:22 pm

    [...] minding the obesity epidemic – jeanne whalen at the wsj has a fascinating piece on a slew of new obesity drugs now in clinical trials. there’s a lot to comment on, but i was struck by a chart on the front page, giving the following rates of obesity (bmi > 30) in … [...]

  8. Man Boob Help | How To Lose Chest Fat | Man Boob Help - October 29, 2009 at 5:43 pm

    [...] minding the obesity epidemic – jeanne whalen at the wsj has a fascinating piece on a slew of new obesity drugs now in clinical trials. there’s a lot to comment on, but i was struck by a chart on the front page, giving the following rates of obesity (bmi > 30) in … [...]

Leave a Reply

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word


  • « Previous post
  • Next post »

Authors

Daniel J. Solove

Website
Understanding Privacy

Kaimipono Wenger

Website
SSRN Page

Dave Hoffman

Website
SSRN Page

Nate Oman

Website
SSRN Page

Frank Pasquale

Website
SSRN Page

Deven Desai

Website
SSRN Page

Danielle Citron

Website
SSRN Page

Lawrence Cunningham

Website
SSRN Page

Sarah Waldeck

Website
SSRN Page

Jaya Ramji-Nogales

Website
SSRN Page

Solangel Maldonado

Website
SSRN Page

Gerard Magliocca

Website
SSRN Page


Guests

Rachel Godsil
Alex Kreit
Anita Krishnakumar
Matthew Sag
Michael Zimmer






Previous Guests

Michael Abramowicz
Michelle Adams
Robert Ahdieh
Michelle Anderson
Laura Appleman
Ann Bartow
Francesca Bignami
Jeremy Blumenthal
Kathleen Boozang
Bruce Boyden
Donald Braman
Al Brophy
Neil H. Buchanan
Bill Burke-White
Scott Burris
Paul Butler
Naomi Cahn
Anupam Chander
Miriam Cherry
Jack Chin
Jennifer Collins
Allison Danner
Brannon Denning
Deven Desai
Mike Dimino
Mark Edwards
David Fagundes
Christine Haight Farley
Kim Ferzan
Dan Filler
Michael Froomkin
Amanda Frost
Timothy Glynn
Rachel Godsil
Eric Goldman
David Gray
Craig Green
Tristin Green
Jeffrey Harrison
Erica Hashimoto
Carissa Hessick
Laura Heymann
Robert Hillman
Christine Hurt
Darian Ibrahim
John Ip
Kevin Johnson
Dan Kahan
Brian Kalt
Sam Kamin
Michael Kang
Chimène Keitner
Orin Kerr
Nancy Kim
Heidi Kitrosser
Adam Kolber
Russell Korobkin
Anita S. Krishnakumar
Susan Kuo
Greg Lastowka
Sarah Lawsky
Erik Lillquist
Jeff Lipshaw
Jonathan Lipson
Jacqueline Lipton
Joseph Liu
Michael Madison
Solangel Maldonado
Jason Mazzone
Linda McClain
William McGeveran
Salil Mehra
Carrie Menkel-Meadow
Max Minzner
Scott Moss
Eric Muller
Jaya Ramji-Nogales
Helen Norton
Elizabeth Nowicki
Paul Ohm
Michael O'Shea
David Opderback
Kristen Osenga
Rafael Pardo
Marcy Peek
Eduardo Peñalver
Robert Percival
David Post
Shruti Rana
Geoffrey Rapp
Neil Richards
Lori Ringhand
Alice Ristroph
Susan Scafidi
Paul Secunda
Jonathan Siegel
Jessica Silbey
Peter Smith
Charles Sullivan
Rick Swedloff
Steph Tai
Andrew Taslitz
Robert Tsai
Jenia Turner
Steve Vladeck
Sarah Waldeck
Melissa Waters
Alfred Yen
David Zaring
Timothy Zick
Spencer Weber Waller
Howard Wasserman
Frank Wu
Corey Yung
Jonathan Zittrain

Blogroll

Above the Law
ACS Blog
Althouse
Balkinization
Becker-Posner Blog
BlackProf
BoingBoing
Chicago Law Faculty Blog
Conglomerate
CrimLaw
Crime & Federalism
CrimProf Blog
Crooked Timber
Discourse.net
Dorf on Law
Election Law
Emergent Chaos
The Faculty Lounge
Feminist Law Profs
43(B)log
Freakonomics Blog
Freedom to Tinker
Google Blogoscoped
How Appealing
Ideoblog
Info/Law
Instapundit.com
Juris Novus
Jurisdynamics
Law and Humanities Blog
Law and Letters
Law Librarian Blog
Legal Profession Blog
Legal Theory Blog
Legal Times Blog
Leiter Reports
Brian Leiter's Law School Reports
Lessig Blog
Madisonian Theory
Media Law Blog
Mirror of Justice
The Moderate Voice
National Security Advisors
Opinio Juris
Point of Law
PrawfsBlawg
ProfessorBainbridge.com
Property Prof Blog
Red Tape Chronicles
The Right Coast
Schneier on Security
SCOTUSBlog
Security Dilemmas
Sentencing Law and Policy
Simple Justice
Sivacracy.net
The Situationist
Susan Crawford
TalkLeft
Talking Points Memo
TaxProf Blog
Tech & Marketing Law
Truth on the Market
Volokh Conspiracy
WorkPlace Prof Blog
WSJ Law Blog
Wonkette
The Yin Blog


© Concurring Opinions

Powered by WordPress